Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Akiko Popiel

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Current Pharmaceutical Design|December 17, 2008
Conformational changes and aggregation of expanded polyglutamine proteins as therapeutic targets of the polyglutamine diseases: exposed beta-sheet hypothesisYoshitaka Nagai, H Akiko Popiel
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 20, 2007
Protein transduction domain-mediated delivery of QBP1 suppresses polyglutamine-induced neurodegeneration in vivoH Akiko Popiel, Yoshitaka Nagai, Nobuhiro Fujikake, et al.
Brain and Nerve = Shinkei Kenkyu No Shinpo|April 24, 2007
[Therapeutic strategies for the polyglutamine diseases]Yoshitaka Nagai, H Akiko Popiel, Nobuhiro Fujikake, et al.
Current Pharmaceutical Biotechnology|February 20, 2010
Induction of molecular chaperones as a therapeutic strategy for the polyglutamine diseasesYoshitaka Nagai, Nobuhiro Fujikake, H Akiko Popiel, et al.
Neuroscience Letters|July 8, 2008
Delivery of the aggregate inhibitor peptide QBP1 into the mouse brain using PTDs and its therapeutic effect on polyglutamine disease miceH Akiko Popiel, Yoshitaka Nagai, Nobuhiro Fujikake, et al.
Current Medicinal Chemistry|February 19, 2014
Peptide-based therapeutic approaches for treatment of the polyglutamine diseasesToshihide Takeuchi, H Akiko Popiel, Shiroh Futaki, et al.
The Journal of Biological Chemistry|July 18, 2008
Heat shock transcription factor 1-activating compounds suppress polyglutamine-induced neurodegeneration through induction of multiple molecular chaperonesNobuhiro Fujikake, Yoshitaka Nagai, H Akiko Popiel, et al.
FEBS Letters|June 28, 2005
Alternative splicing regulates the transcriptional activity of Drosophila heat shock transcription factor in response to heat/cold stressNobuhiro Fujikake, Yoshitaka Nagai, H Akiko Popiel, et al.
The Journal of Biological Chemistry|June 19, 2007
Detection of polyglutamine protein oligomers in cells by fluorescence correlation spectroscopyYasuo Takahashi, Yuma Okamoto, H Akiko Popiel, et al.
Biochemical and Biophysical Research Communications|December 9, 2008
Surface plasmon resonance characterization of specific binding of polyglutamine aggregation inhibitors to the expanded polyglutamine stretchYuma Okamoto, Yoshitaka Nagai, Nobuhiro Fujikake, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Pharmaceutical Design|December 17, 2008
Conformational changes and aggregation of expanded polyglutamine proteins as therapeutic targets of the polyglutamine diseases: exposed beta-sheet hypothesisYoshitaka Nagai, H Akiko Popiel
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 20, 2007
Protein transduction domain-mediated delivery of QBP1 suppresses polyglutamine-induced neurodegeneration in vivoH Akiko Popiel, Yoshitaka Nagai, Nobuhiro Fujikake, et al.
Brain and Nerve = Shinkei Kenkyu No Shinpo|April 24, 2007
[Therapeutic strategies for the polyglutamine diseases]Yoshitaka Nagai, H Akiko Popiel, Nobuhiro Fujikake, et al.
Current Pharmaceutical Biotechnology|February 20, 2010
Induction of molecular chaperones as a therapeutic strategy for the polyglutamine diseasesYoshitaka Nagai, Nobuhiro Fujikake, H Akiko Popiel, et al.
Neuroscience Letters|July 8, 2008
Delivery of the aggregate inhibitor peptide QBP1 into the mouse brain using PTDs and its therapeutic effect on polyglutamine disease miceH Akiko Popiel, Yoshitaka Nagai, Nobuhiro Fujikake, et al.
Current Medicinal Chemistry|February 19, 2014
Peptide-based therapeutic approaches for treatment of the polyglutamine diseasesToshihide Takeuchi, H Akiko Popiel, Shiroh Futaki, et al.
The Journal of Biological Chemistry|July 18, 2008
Heat shock transcription factor 1-activating compounds suppress polyglutamine-induced neurodegeneration through induction of multiple molecular chaperonesNobuhiro Fujikake, Yoshitaka Nagai, H Akiko Popiel, et al.
FEBS Letters|June 28, 2005
Alternative splicing regulates the transcriptional activity of Drosophila heat shock transcription factor in response to heat/cold stressNobuhiro Fujikake, Yoshitaka Nagai, H Akiko Popiel, et al.
The Journal of Biological Chemistry|June 19, 2007
Detection of polyglutamine protein oligomers in cells by fluorescence correlation spectroscopyYasuo Takahashi, Yuma Okamoto, H Akiko Popiel, et al.
Biochemical and Biophysical Research Communications|December 9, 2008
Surface plasmon resonance characterization of specific binding of polyglutamine aggregation inhibitors to the expanded polyglutamine stretchYuma Okamoto, Yoshitaka Nagai, Nobuhiro Fujikake, et al.
Pageof 2